< Back to companies
GeneDX

GeneDX

Stamford, Connecticut, United States

GeneDx, (Nasdaq: WGS) delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by one of the world’s largest rare disease data sets.

Only accessible to MedStartr community members. Join now

Company Info

Founded
2015
Website
www.genedx.com/

Categories

Cancer

Disease Areas

Technologies

Data ScienceAnalytics & BIPredictive ModelingGenomics
Only accessible to MedStartr community members. Join now

What do you think of GeneDX?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now